Pancreatic protective effects of sodium tungstate in streptozotocin-induced diabetic rats
详细信息    查看全文
文摘

Summary

Aims

A number of chemical compounds such as sodium tungstate and vanadyl sulfate have been assessed for their anti-diabetic effects in several animal models of diabetes. This study investigates the proper time for initiation of sodium tungstate treatment in diabetic Wistar rats and its histopathological effects on pancreas.

Materials and methods

Animals were divided into five groups (n = 10). Control (C), sodium tungstate-treated control (TC), streptozotocin-induced diabetic (D), streptozotocin-induced diabetic rats were treated by sodium tungstate form 1 week before streptozotocin (STZ) injection (TD1), and diabetic rats treated with sodium tungstate 1 week after STZ administration (TD2). The histopathologic changes in pancreas were investigated by light microscopy. Body weight, blood glucose, insulin levels, food intake and fluid intake were compared between groups. Serum insulin levels were determined by ultra-sensitive rat insulin kit, using double-antibody ELISA.

Results

Group D and TD2 showed significant weight loss, polydipsia, polyuria and polyphagia compared to groups C and TC (p < 0.01). TD1 group protects diabetic-induced rats from elevation of glucose compared to groups D and TD2 (p < 0.01). Group TD1 showed significant decrease in fasting glucose levels and oral glucose tolerance test in comparison to groups D and TD2 (p < 0.01). Microscopic evaluation of pancreas showed that in TD1 group, tungstate protects STZ-induced beta-cells degenerations.

Conclusion

Pre-treatment with sodium tungstate leads to amelioration of diabetic complications and short-term pre-treatment with tungstate can converts the diabetic state by sustaining a few, although it is critical, amount of beta-cells that adequately maintain normoglycemia.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700